Product Information
OXAZEPAM 30 MG CAPSULE is a generic product labeled by American Health Packaging, priced at $1.2342 per EA under NDC 62584081401. Its NADAC has been published 595 times since Nov 28, 2013.
FDA first approved this application on Apr 14, 1988. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
American Health PackagingNDC
62584081401
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA072253FDA Approved
4/14/1988
TE Code
AB
On Market Since
12/17/2007
Pharmacological Classes
Price Statistics
The NADAC for OXAZEPAM 30 MG CAPSULE has been published 595 times since Nov 28, 2013, and over the history we have for it it has declined 3.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2342 per EA |
|---|---|
| All-time high | $1.5994 (Apr 13, 2016) |
| All-time low | $1.0556 (Feb 18, 2015) |
| 52-week high | $1.3640 |
| 52-week low | $1.1218 |
| Median price | $1.3449 |
| Average price | $1.3371 |
| Largest weekly change | +34.0% (Dec 23, 2015) |
| Weeks tracked | 595 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXAZEPAM 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OXAZEPAM 30 MG CAPSULE, manufactured by American Health Packaging, is $1.2342 per EA (NDC 62584081401), effective Aug 19, 2026.
How has the price of OXAZEPAM 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OXAZEPAM 30 MG CAPSULE has declined 3.3%. It has been tracked across 595 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for OXAZEPAM 30 MG CAPSULE?
Since Nov 28, 2013, the NADAC for OXAZEPAM 30 MG CAPSULE has ranged from a low of $1.0556 (Feb 18, 2015) to a high of $1.5994 (Apr 13, 2016), with a median of $1.3449 per EA.
Are there cheaper alternatives to OXAZEPAM 30 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXAZEPAM 30 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures OXAZEPAM 30 MG CAPSULE?
OXAZEPAM 30 MG CAPSULE (NDC 62584081401) is labeled by American Health Packaging, and CMS classifies it as a generic product.